Patients with rare diseases to get DNA sequenced at no charge
Scientists at Washington University School of
Medicine in St. Louis, including Jimmy Lin, PhD, are reaching out to patient advocacy groups and
offering to decode the DNA of 99 patients with rare diseases to help
find the genetic alterations responsible for their illnesses. The patients’ DNA will be sequenced by the university’s Genomics and Pathology Services (GPS) at no cost to patients or advocacy groups.
New service brings power of genomics to patient care
Genomics and Pathology Services at Washington University School of Medicine in St. Louis (GPS@WUSTL), directed by Karen Seibert, PhD, is now offering a test for mutations in 28 genes associated with cancer. The genes in the test affect a variety of different types of tumors, including blood, lymph, lung, brain, bladder, kidney, skin, stomach, prostate and breast cancers.